Search

Issue
Title
Authors
Vol 30, No 3 (2023)
Combination therapy for type 2 diabetes maintains its position. Clinical case
Podachina S.V., Biryukova E.V., Solovievа I.V.
PDF
(Rus)
Vol 30, No 12 (2023)
Metabolic effects of metformin in patients with type 2 diabetes mellitus and new coronavirus infection
Zhurtova I.B., Gubachikova A.M., Aramisova L.S., Anaeva L.A., Abdul Moati H.A.
PDF
(Rus)
Vol 30, No 4/5 (2023)
Pharmacotherapeutic aspects of gestational diabetes mellitus against the background of impaired maternal immunity
Kazimova A.U., Polukhova S.M.
PDF
(Rus)
Vol 29, No 4 (2022)
Type 3 diabetes mellitus: is there a chance to become famous?
Morgunov L.Y.
PDF
(Rus)
No 16 (2016)
Modern approaches to the treatment of patients with type 2 diabetes mellitus
Antsiferov M.B., Fadeev V.V., Morgunova T.B.
PDF
(Rus)
No 16 (2013)
Preimushchestva novoy fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysbozhdeniya v terapii sakharnogo diabeta 2 tipa
Ametov A.S.
PDF
(Rus)
No 3 (2012)
HOW TO EFFECTIVELY MANAGE TWO MAJOR DEFECTS IN TYPE 2 DIABETES MELLITUS?
Biryukova E.V., Antsiferov M.B., Biryukova Y.V., Antsiferov M.B.
No 15 (2009)
Insulin resistance and heart diseases: is there a relationship?
Drapkina O.M., Smirin V.I., Ivashkin V.T., Drapkina O.M., Smirin V.I., Ivaschkin V.T.
Vol 28, No 12 (2021)
Differentiated approach to metformin therapy in newly diagnosed type 2 diabetes mellitus from the perspective of pharmacogenetics
Shorokhova P.B., Baranov V.L.
PDF
(Rus)
No 5 (2016)
APPLICATION OF SAXAGLIPTIN AND ITS COMBINATION WITH METFORMIN IN THE THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS
Antsiferov M.B.
PDF
(Rus)
No 10 (2013)
Rannyaya diagnostika i lechenie narushennoy glikemii natoshchak zamedlyaet tempy ee konversii v narushennuyu tolerantnost' k glyukoze i sakharnyy diabet 2 tipa
Demidova I.Y., Boeva V.V.
PDF
(Rus)
No 16 (2011)
Galvus and Galvus Met in treatment of elderly patients with type 2 diabetes mellitu
Antsiferov M.B., Antciferov M.B.
No 3 (2009)
Metformin - pathogenetic drug of first-line in the treatment of type 2 diabetes
Zilov A.V., Zilov A.V.
Vol 28, No 12 (2021)
Insulin resistance - a common enemy for endocrinologists and cardiologists
Verbovoy A.F., Dolgikh Y.A.
PDF
(Rus)
No 17 (2015)
Gipoglikemiya i kachestvo zhizni bol'nykh sakharnym diabetom 2 tipa
Antsiferov M.B., Nikitina T.P., Rodionova A.Y., Kurbatova K.A., Ionova T.I.
PDF
(Rus)
No 5 (2013)
PREIMUShchESTVA METFORMINA PROLONGIROVANNOGO DEYSTVIYa
Petunina N.A., Trukhina L.V., Sinitsyna E.I., Antsiferov M.B.
PDF
(Rus)
No 16 (2011)
DIPEPTIDYL PEPTIDASE-4 INHIBITORS - NEW POTENTIALS FOR TREATMENT OF TYPE 2 DIABETES MELLITUS: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M.B., Antciferov M.B.
No 3 (2009)
Vildagliptin - a new dipeptidylpeptidase-4 inhibitor for the treatment of type 2 diabetes mellitus
Antsiferov M.B., Dorofeeva L.G., Anciferov M.B., Dorofeeva L.G.
Vol 27, No 12 (2020)
Effect of Subetta on glycemic control in patients with type 2 diabetes mellitus: results of a multicenter, double-blind, placebo-controlled, randomized clinical study
Mkrtumyan A.M., Vorobyev S.V., Volkova A.R., Vorokhobina N.V.
PDF
(Rus)
No 5 (2015)
Preimushchestva fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysvobozhdeniya (Kombogliz Prolong) v terapii SD 2 tipa
Ametov A.S.
PDF
(Rus)
No 5 (2013)
FARMAKOEKONOMIChESKIY ANALIZ PREIMUShchESTV KOMBINIROVANNOY INKRETINOVOY TERAPII BOL'NYKh SAKhARNYM DIABETOM 2 TIPA NA PRIMERE VILDAGLIPTINA
Arinina E.E., Rashid M.A., Antsiferov M.B.
PDF
(Rus)
No 5 (2011)
PATHOPHYSIOLOGICAL FEATURES OF TREATMENT OF ARTERIAL HYPERTENSION AND DISORDERS OF CARBOHYDRATE METABOLISM.
Shilov A.M., Osiya A.O., Dulaeva M.S., Eremina I.V., Shilov A.M., Osia A.O., Dulayeva M.S., Yeremina I.V.
Vol 27, No 12 (2020)
Combination of two hypoglycemic drugs for type 2 diabetes mellitus
Morgunova T.B., Fadeyev V.V.
PDF
(Rus)
No 16 (2014)
Primenenie kombinirovannoy terapii glimepiridom i metforminom u patsientov s sakharnym diabetom 2 tipa. Rezul'taty Rossiyskogo observatsionnogo issledovaniya
Zaytseva N.V., Shamkhalova M.S.
PDF
(Rus)
No 1 (2013)
METABOLIChESKIY SINDROM U DETEY: SOVREMENNYY VZGLYaD NA PROBLEMU
Zakharova I.N., Yablochkova S.V.
PDF
(Rus)
No 3 (2011)
CLINICAL ASPECTS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: BENEFITS FOR DIFFERENT GROUPS OF PATIENTS
Antsiferov M.B., Antsiferov M.B.
Vol 26, No 14 (2019)
Start of therapy of type 2 diabetes mellitus with a fixed combination. Metformin with vildagliptin or glibenclamide, is there any difference?
Demidov N.A., Koteshkova O.M., Balberova M.A., Antsiferov M.B.
PDF
(Rus)
No 16 (2014)
Fiksirovannaya kombinatsiya saksagliptina i metformina modifitsirovannogo vysvobozhdeniya - novyy shag v uluchshenii priverzhennosti k lecheniyu sakharnogo diabeta 2 tipa
Biryukova E.V.
PDF
(Rus)
No 16 (2012)
Ratsional'naya farmakoterapiya SD 2 tipa: primenenie ingibitora DPP-4 saksagliptina i metformina v klinicheskoy praktike
Ametov A.S., Brashchenkova A.V.
PDF
(Rus)
No 3 (2011)
COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N.A., Trukhina L.V., Petunina N.A., Truhina L.V.
Vol 29, No 11/12 (2022)
Cardiovascular outcomes during treatment with dipeptidyl peptidase-4 inhibitors depending on renal function and combination with metformin: a systematic review
Petunina N.A., Martirosyan N.S., Valeeva F.V.
PDF
(Rus)
Vol 26, No 4 (2019)
Do we know everything about the possibilities of metformin in the treatment of type 2 diabetes mellitus? Which of its combinations is the most studied, effective and available for the patient in the real practice of the endocrinologist?
Biryukova E.V., Solovyova I.V.
PDF
(Rus)
No 5 (2014)
METFORMIN - NADEZhNYY PARTNER V LEChENII PATsIENTOV S SAKhARNYM DIABETOM 2 TIPA
Petunina N.A., Kuzina I.A.
PDF
(Rus)
No 7 (2012)
DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M.B., Antsiferov M.B.
No 16 (2010)
WHEN TO BEGIN COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N.A., Petunina N.A.
Vol 29, No 11/12 (2022)
Clinical effects of dapagliflozin in patients with type 2 diabetes mellitus and paroxysmal atrial fibrillation
Bagriy A.E., Prikolota O.A., Prikolota A.V., Mikhailichenko E.S., Golodnikov I.A., Bagriy O.N., Kotova K.A.
PDF
(Rus)
No 4 (2018)
POSSIBILITIES OF METHORMINE IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS: TEST OF TIME
Biryukova E.V., Solovyeva I.V., Platonova N.M.
PDF
(Rus)
No 5 (2014)
VLIYaNIE KOMBINATsII METFORMINA I VILDAGLIPTINA NA POKAZATELI UGLEVODNOGO I ZhIROVOGO OBMENOV U BOL'NYKh SAKhARNYM DIABETOM 2 TIPA
Abaeva M.S., Nazhmutdinova P.K., Ametov A.S.
PDF
(Rus)
No 3 (2012)
SUSTAINED-RELEASE METFORMIN (GLUCOPHAGE LONG) IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Nikonova T.V., Nikonova T.V.
No 16 (2010)
POTENTIALS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN TYPE 2 DIABETES MELLITUS: INITIATION AND CONTINUATION OF THERAPY
Antsiferov M.B., Zilov A.V., Antsiferov M.B., Zilov A.V.
1 - 40 of 40 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies